IM Cannabis Corp (IMCC)
0.72
0.00 (0.00%)
USD |
NASDAQ |
May 15, 16:00
0.74
+0.02
(+2.78%)
After-Hours: 20:00
IM Cannabis Gross Profit Margin (Quarterly): 14.75% for March 31, 2024
Gross Profit Margin (Quarterly) Chart
Historical Gross Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2024 | 14.75% |
| December 31, 2023 | 19.76% |
| September 30, 2023 | 23.63% |
| June 30, 2023 | 26.17% |
| March 31, 2023 | 23.18% |
| December 31, 2022 | 17.95% |
| September 30, 2022 | 16.45% |
| June 30, 2022 | 17.33% |
| Date | Value |
|---|---|
| March 31, 2022 | 18.50% |
| December 31, 2021 | 9.88% |
| September 30, 2021 | -0.93% |
| June 30, 2021 | -5.11% |
| March 31, 2021 | 57.35% |
| December 31, 2020 | 10.35% |
| September 30, 2020 | 57.37% |
| June 30, 2020 | 52.91% |
Gross Profit Margin Definition
Gross Profit Margin is calculated using Gross Profit/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into gross profit and doing this by keeping cost of goods sold low. An analyst looking at gross profit margin might look for a higher gross profit margin relative to other comparable companies as well as a gross profit margin that is growing.
Gross Profit Margin (Quarterly) Range, Past 5 Years
-5.11%
Minimum
Jun 2021
57.37%
Maximum
Sep 2020
22.47%
Average
18.22%
Median
Gross Profit Margin (Quarterly) Benchmarks
| Taro Pharmaceutical Industries Ltd | 50.83% |
| InspireMD Inc | 28.68% |
| BiomX Inc | -- |
| Alpha Tau Medical Ltd | -- |
| Pluri Inc | -- |
Gross Profit Margin (Quarterly) Related Metrics
| Return on Equity | -131.7% |
| Return on Assets | -45.42% |
| Return on Invested Capital | -80.66% |
| Profit Margin (Quarterly) | -49.90% |
| Operating Margin (Quarterly) | -46.67% |
| Return on Net Operating Assets | -49.35% |